Joseph Bollen
Overview
Explore the profile of Joseph Bollen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendlewicz J, Crisafulli C, Calati R, Kocabas N, Massat I, Linotte S, et al.
Neurosci Lett
. 2012 Apr;
516(1):85-8.
PMID: 22487732
Inflammatory pathways play a crucial role in the pathomechanisms of antidepressant efficacy. The aim of this study was to investigate whether a set of single nucleotide polymorphisms (SNPs) within cyclooxygenase-2...
2.
Serretti A, Chiesa A, Crisafulli C, Massat I, Linotte S, Calati R, et al.
Neuropsychobiology
. 2012 Jan;
65(2):70-5.
PMID: 22222462
In the present study, we aimed to confirm the previous finding of an association between GRIK4 and GNB3 variants (rs195478 and rs5443) and remission and treatment resistance in major depression,...
3.
Souery D, Serretti A, Calati R, Oswald P, Massat I, Konstantinidis A, et al.
J Clin Psychopharmacol
. 2011 Jun;
31(4):512-6.
PMID: 21694617
Objective: The management of treatment-resistant depression is a much debated issue. In particular, the evidence supporting the commonly suggested sequential use of antidepressants from 2 different pharmacological classes is weak....
4.
Massat I, Kocabas N, Crisafulli C, Chiesa A, Calati R, Linotte S, et al.
Neurosci Lett
. 2011 May;
498(3):218-21.
PMID: 21600957
Our study aims at replicating our previous finding of an association between COMT rs4680 G/A polymorphism and early onset major depression (MD). We included 462 MD, 147 bipolar disorders (BD)...
5.
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression
Serretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, et al.
Psychiatry Res
. 2010 Dec;
188(1):166-9.
PMID: 21168919
In the present study, aimed at investigating whether a set of single nucleotide polymorphisms (SNPs) within PTGS2 gene (rs4648276, rs2066826 and rs689466) could be associated with antidepressant response, remission and...
6.
Serretti A, Chiesa A, Calati R, Massat I, Linotte S, Kasper S, et al.
J Affect Disord
. 2010 Jul;
128(1-2):56-63.
PMID: 20643483
Background: The transcription factor Cyclic adenosine monophosphate Response Element Binding (CREB) protein has been repeatedly involved in the aetiology and pharmacotherapy of major depression (MD). The aim of this study...
7.
Serretti A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, et al.
Int Clin Psychopharmacol
. 2009 Jul;
24(5):250-6.
PMID: 19593158
Cytochrome P450 genes are involved in the metabolism of antidepressants and could influence treatment response. The aim of this study was to investigate the role of allelic variations of the...
8.
Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, et al.
J Clin Psychiatry
. 2007 Aug;
68(7):1062-70.
PMID: 17685743
Objectives: Very few studies have investigated clinical features associated with treatment-resistant depression (TRD) defined as failure of at least 2 consecutive antidepressant trials. The primary objective of this multicenter study...